These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 15201857)

  • 1. Immediate changes in lung compliance following natural surfactant administration in premature infants with respiratory distress syndrome: a controlled trial.
    Attar MA; Becker MA; Dechert RE; Donn SM
    J Perinatol; 2004 Oct; 24(10):626-30. PubMed ID: 15201857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Infasurf (calf lung surfactant extract) to Survanta (Beractant) in the treatment and prevention of respiratory distress syndrome.
    Bloom BT; Kattwinkel J; Hall RT; Delmore PM; Egan EA; Trout JR; Malloy MH; Brown DR; Holzman IR; Coghill CH; Carlo WA; Pramanik AK; McCaffree MA; Toubas PL; Laudert S; Gratny LL; Weatherstone KB; Seguin JH; Willett LD; Gutcher GR; Mueller DH; Topper WH
    Pediatrics; 1997 Jul; 100(1):31-8. PubMed ID: 9200357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicenter, randomized trial comparing synthetic surfactant with modified bovine surfactant extract in the treatment of neonatal respiratory distress syndrome. Vermont-Oxford Neonatal Network.
    Pediatrics; 1996 Jan; 97(1):1-6. PubMed ID: 8545199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified bovine surfactant (Survanta) versus a protein-free surfactant (Exosurf) in the treatment of respiratory distress syndrome in preterm infants: a pilot study.
    Sehgal SS; Ewing CK; Richards T; Taeusch HW
    J Natl Med Assoc; 1994 Jan; 86(1):46-52. PubMed ID: 8151722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early administration of the second surfactant dose in preterm infants with severe respiratory distress syndrome.
    Köksal N; Akpinar R; Cetinkaya M
    Turk J Pediatr; 2009; 51(6):556-64. PubMed ID: 20196389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized clinical trial comparing two natural surfactant preparations to treat respiratory distress syndrome.
    Hammoud M; Al-Kazmi N; Alshemmiri M; Thalib L; Ranjani VT; Devarajan LV; Elsori H
    J Matern Fetal Neonatal Med; 2004 Mar; 15(3):167-75. PubMed ID: 15280142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A controlled clinical comparison of four different surfactant preparations in surfactant-deficient preterm lambs.
    Cummings JJ; Holm BA; Hudak ML; Hudak BB; Ferguson WH; Egan EA
    Am Rev Respir Dis; 1992 May; 145(5):999-1004. PubMed ID: 1586078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized trial comparing two natural surfactants (Survanta vs. bLES) for treatment of neonatal respiratory distress syndrome.
    Lam BC; Ng YK; Wong KY
    Pediatr Pulmonol; 2005 Jan; 39(1):64-9. PubMed ID: 15558604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes of respiratory system mechanics in ventilated lungs of preterm infants with two different schedules of surfactant treatment.
    de Winter JP; Merth IT; van Bel F; Egberts J; Brand R; Quanjer PH
    Pediatr Res; 1994 May; 35(5):541-9. PubMed ID: 8065835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional residual capacity and compliance of the respiratory system after surfactant treatment in premature infants with severe respiratory distress syndrome.
    Dinger J; Töpfer A; Schaller P; Schwarze R
    Eur J Pediatr; 2002 Sep; 161(9):485-90. PubMed ID: 12200607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perfusion index variability in preterm infants treated with two different natural surfactants for respiratory distress syndrome.
    Karadag N; Dilli D; Zenciroglu A; Aydin B; Beken S; Okumus N
    Am J Perinatol; 2014 Nov; 31(11):1015-22. PubMed ID: 24566756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary surfactant deficiency in neonates.
    Bissinger R; Carlson C; Hulsey T; Eicher D
    J Perinatol; 2004 Oct; 24(10):663-6. PubMed ID: 15229621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid improvement of static compliance after surfactant treatment in preterm infants with respiratory distress syndrome.
    Baraldi E; Pettenazzo A; Filippone M; Magagnin GP; Saia OS; Zacchello F
    Pediatr Pulmonol; 1993 Mar; 15(3):157-62. PubMed ID: 8327278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevention and treatment of respiratory distress syndrome in premature infants using intratracheally administered surfactants].
    de Winter JP; Egberts J; de Kleine MJ; van Bel F; Wijnands JB; Guit GL
    Ned Tijdschr Geneeskd; 1992 Oct; 136(41):2018-24. PubMed ID: 1407193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effectiveness of surfactant replacement therapy for preterm infants with respiratory distress syndrome.
    Lim WL; Lim CT; Chye JK
    Med J Malaysia; 1998 Dec; 53(4):376-84. PubMed ID: 10971981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric calfactant in acute respiratory distress syndrome trial.
    Willson DF; Thomas NJ; Tamburro R; Truemper E; Truwit J; Conaway M; Traul C; Egan EE;
    Pediatr Crit Care Med; 2013 Sep; 14(7):657-65. PubMed ID: 23846250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomised clinical trial of two treatment regimens of natural surfactant preparations in neonatal respiratory distress syndrome.
    Speer CP; Gefeller O; Groneck P; Laufkötter E; Roll C; Hanssler L; Harms K; Herting E; Boenisch H; Windeler J
    Arch Dis Child Fetal Neonatal Ed; 1995 Jan; 72(1):F8-13. PubMed ID: 7743295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Two Different Exogenous Surfactant Preparations on Serial Peripheral Perfusion Index and Tissue Carbon Monoxide Measurements in Preterm Infants with Severe Respiratory Distress Syndrome.
    Terek D; Gonulal D; Koroglu OA; Yalaz M; Akisu M; Kultursay N
    Pediatr Neonatol; 2015 Aug; 56(4):248-55. PubMed ID: 25603725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early surfactant for neonates with mild to moderate respiratory distress syndrome: a multicenter, randomized trial.
    Escobedo MB; Gunkel JH; Kennedy KA; Shattuck KE; Sánchez PJ; Seidner S; Hensley G; Cochran CK; Moya F; Morris B; Denson S; Stribley R; Naqvi M; Lasky RE;
    J Pediatr; 2004 Jun; 144(6):804-8. PubMed ID: 15192630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter trial of single-dose modified bovine surfactant extract (Survanta) for prevention of respiratory distress syndrome. Ross Collaborative Surfactant Prevention Study Group.
    Soll RF; Hoekstra RE; Fangman JJ; Corbet AJ; Adams JM; James LS; Schulze K; Oh W; Roberts JD; Dorst JP
    Pediatrics; 1990 Jun; 85(6):1092-102. PubMed ID: 2187176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.